GH1 and acromegaly: As seen in Fig. 3C, hepatic triglyceride export in patients with acromegaly did not significantly differ compared to our unmatched group of healthy males before GH-axis modulation (P = .628) and IHL of patients was low and comparable to previous studies (18, 19).